The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Estrogen biology: New insights into GPER function and clinical opportunities
Open accessAbstract
Estrogens play an important role in the regulation of normal physiology, aging and many disease states. Although the nuclear estrogen receptors have classically been described to function as ligand-activated transcription factors mediating genomic effects in hormonally regulated tissues, more recent studies reveal that estrogens also mediate rapid signaling events traditionally associated with G protein-coupled receptors. The G protein-coupled estrogen receptor GPER (formerly GPR30) has now become recognized as a major mediator of estrogen’s rapid cellular effects throughout the body. With the discovery of selective synthetic ligands for GPER, both agonists and antagonists, as well as the use of GPER knockout mice, significant advances have been made in our understanding of GPER function at the cellular, tissue and organismal levels. In many instances, the protective/beneficial effects of estrogen are mimicked by selective GPER agonism and are absent or reduced in GPER knockout mice, suggesting an essential or at least parallel role for GPER in the actions of estrogen. In this review, we will discuss recent advances and our current understanding of the role of GPER and certain drugs such as SERMs and SERDs in physiology and disease. We will also highlight novel opportunities for clinical development towards GPER-targeted therapeutics, for molecular imaging, as well as for theranostic approaches and personalized medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–219 of 219
Immunomodulatory effects of anti-estrogenic drugs
Ray, A., & Ficek, M. (2012) · Acta Pharmaceutica · doi:10.2478/v10007-012-0012-3 · Cited by 28
Ren, J., & Wu, J. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9581-x · Cited by 28
Brailoiu, G. C., Arterburn, J. B., Oprea, T. I., Chitravanshi, V. C., & Brailoiu, E. (2012) · Experimental Physiology · doi:10.1113/expphysiol.2012.069377 · Cited by 28
Washburn, N., Borgquist, A., Wang, K., Jeffery, G. S., Kelly, M. J., & Wagner, E. J. (2012) · Neuroendocrinology · doi:10.1159/000338669 · Cited by 27
Estrogens as Potential Therapeutic Agents in Multiple Sclerosis
Niino, M., Hirotani, M., Fukazawa, T., Kikuchi, S., & Sasaki, H. (2009) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152409788452054 · Cited by 26
Holm, A., Hellstrand, P., Olde, B., Svensson, D., Leeb-Lundberg, L. M. F., & Nilsson, B. (2013) · Journal of Vascular Research · doi:10.1159/000354252 · Cited by 23
Nayak, T. K., Dennis, M. K., Ramesh, C., Burai, R., Atcher, R. W., Sklar, L. A., Norenberg, J. P., Hathaway, H. J., Arterburn, J. B., & Prossnitz, E. R. (2010) · ACS Chemical Biology · doi:10.1021/cb1000636 · Cited by 23
Self-citationBurai, R., Ramesh, C., Nayak, T. K., Dennis, M. K., Bryant, B. K., Prossnitz, E. R., & Arterburn, J. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046861 · Cited by 23
Self-citationJang, E. J., Seok, Y. M., Arterburn, J. B., Olatunji, L. A., & Kim, I. K. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12113 · Cited by 23
Ylikomi, T. J., Vienonen, A., & Ahola, T. M. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04353.x · Cited by 22
Zhu, P., Yuen, J. M. L., Sham, K. W. Y., & Cheng, C. H. K. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.07.004 · Cited by 21
Identification and Characterization of New Mechanisms in Vascular Oestrogen Signalling
Holm, A., & Nilsson, B. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12118 · Cited by 19
Contribution of GPR30 for 1,25 dihydroxyvitamin D3 protection in EAE
Subramanian, S., Miller, L., Grafe, M. R., Vandenbark, A. A., & Offner, H. (2011) · Metabolic Brain Disease · doi:10.1007/s11011-011-9266-6 · Cited by 18
Regulation of Calcium Sensing Receptor Trafficking by RAMPs
Bouschet, T., Martin, S. S., & Henley, J. M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-2364-5_4 · Cited by 14
Alike but Not the Same: Anatomic Heterogeneity of Estrogen Receptor-mediated Vasodilation
Barton, M., Meyer, M. R., & Prossnitz, E. R. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31829709d4 · Cited by 14
Self-citationLoss of Rapid Estrogen-Induced Cardioprotection in GPER-/- Mice After Ischemia and Reperfusion
Bopassa, J. C., Leeb‐Lundberg, L. M. F., Olde, B., Toro, L., & Stefani, E. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2010.12.1809 · Cited by 4
Bopassa, J. C., Lü, R., Singh, H., Olde, B., Krust, A., Leeb-Lundberg, L. M. F., Toro, L., & Stefani, E. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2011.11.775 · Cited by 3
Schiffrin, E. L. (2013) · Circulation Research · doi:10.1161/circresaha.113.300883 · Cited by 3
Bopassa, J. C., Lu, R., Singh, H., Zilberstein, N., Olde, B., Krust, A., Leeb-Lundberg, L. M. F., Toro, L., & Stefani, E. (2012) · Circulation Research · doi:10.1161/res.111.suppl_1.a213 · Cited by 3
Cited by
Estrogen receptor signaling mechanisms
(2019) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.01.001 · Cited by 988
Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse
Hara, Y., Waters, E. M., McEwen, B. S., & Morrison, J. H. (2015) · Physiological Reviews · doi:10.1152/physrev.00036.2014 · Cited by 470
Molecular mechanism of estrogen–estrogen receptor signaling
Yaşar, P., Ayaz, G., User, S. D., Güpür, G., & Muyan, M. (2017) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12006 · Cited by 482
Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics
Puré, E., & Blomberg, R. (2018) · Oncogene · doi:10.1038/s41388-018-0275-3 · Cited by 391
Role of estrogen receptors in health and disease
Chen, P., Li, B., & Ou-Yang, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.839005 · Cited by 339
Metadata
- Authors
- Prossnitz, E. R., & Barton, M.
- Venue
- Molecular and Cellular Endocrinology
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 389
- Issue
- 1-2
- Pages
- 71-83
- ISSN
- 0303-7207 (ISSN-L)
- OpenAlex
- W2012644882
- Cited by
- 400
- References
- 219
- FWCI
- 24.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.